Stock Analysis
Yidu Tech (HKG:2158) Full Year 2024 Results
Key Financial Results
- Revenue: CN¥807.1m (flat on FY 2023).
- Net loss: CN¥194.9m (loss narrowed by 69% from FY 2023).
- CN¥0.18 loss per share (improved from CN¥0.63 loss in FY 2023).
All figures shown in the chart above are for the trailing 12 month (TTM) period
Yidu Tech EPS Beats Expectations
Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 7.1%.
The primary driver behind last 12 months revenue was the Life Sciences Solutions segment contributing a total revenue of CN¥324.0m (40% of total revenue). Notably, cost of sales worth CN¥468.4m amounted to 58% of total revenue thereby underscoring the impact on earnings. The largest operating expense was General & Administrative costs, amounting to CN¥269.9m (39% of total expenses). Over the last 12 months, the company's earnings were enhanced by non-operating gains of CN¥156.9m. Explore how 2158's revenue and expenses shape its earnings.
Looking ahead, revenue is forecast to grow 14% p.a. on average during the next 3 years, compared to a 17% growth forecast for the Healthcare Services industry in Asia.
Performance of the market in Hong Kong.
The company's shares are down 2.6% from a week ago.
Risk Analysis
You still need to take note of risks, for example - Yidu Tech has 1 warning sign we think you should be aware of.
New: Manage All Your Stock Portfolios in One Place
We've created the ultimate portfolio companion for stock investors, and it's free.
• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
About SEHK:2158
Yidu Tech
An investment holding company, provides healthcare solutions built on big data and artificial intelligence (AI) technologies in the People’s Republic of China, Brunei, Singapore, and internationally.
